As previously described, miR-34a is a tumor suppressor which is down-regulated in several types of cancer, including MM, and its mechanism appears to be related to the direct modulation of certain targets such as Bcl-2 and CDK6. This evidence concerns the gene BCL2 and Miyoshi myopathy.